HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,000 | +45.5% | 15,221 | +65.5% | 0.00% | – |
| Q2 2023 | $11,000 | -38.9% | 9,195 | -20.4% | 0.00% | – |
| Q1 2023 | $18,000 | -58.1% | 11,550 | -32.3% | 0.00% | – |
| Q4 2022 | $43,000 | +72.0% | 17,070 | +180.9% | 0.00% | – |
| Q3 2022 | $25,000 | 0.0% | 6,077 | -29.2% | 0.00% | – |
| Q2 2022 | $25,000 | -85.8% | 8,584 | -72.2% | 0.00% | – |
| Q1 2022 | $176,000 | -53.2% | 30,828 | -25.1% | 0.00% | – |
| Q4 2021 | $376,000 | +29.7% | 41,176 | +51.8% | 0.00% | – |
| Q3 2021 | $290,000 | -17.8% | 27,117 | +19.2% | 0.00% | – |
| Q2 2021 | $353,000 | -11.3% | 22,747 | -7.5% | 0.00% | – |
| Q1 2021 | $398,000 | +1.8% | 24,582 | +33.1% | 0.00% | – |
| Q4 2020 | $391,000 | +33.9% | 18,464 | -6.3% | 0.00% | – |
| Q3 2020 | $292,000 | +9.4% | 19,695 | +8.0% | 0.00% | – |
| Q2 2020 | $267,000 | -5.0% | 18,236 | -23.9% | 0.00% | – |
| Q1 2020 | $281,000 | -75.6% | 23,960 | -51.1% | 0.00% | – |
| Q4 2019 | $1,151,000 | +249.8% | 49,022 | +176.3% | 0.00% | – |
| Q3 2019 | $329,000 | -44.3% | 17,740 | -44.2% | 0.00% | – |
| Q2 2019 | $591,000 | +93.8% | 31,767 | +154.6% | 0.00% | – |
| Q1 2019 | $305,000 | +400.0% | 12,477 | +428.2% | 0.00% | – |
| Q4 2018 | $61,000 | -52.3% | 2,362 | -41.6% | 0.00% | – |
| Q3 2018 | $128,000 | +28.0% | 4,046 | +55.9% | 0.00% | – |
| Q2 2018 | $100,000 | +1566.7% | 2,596 | +1142.1% | 0.00% | – |
| Q1 2018 | $6,000 | -91.5% | 209 | -94.7% | 0.00% | – |
| Q4 2017 | $71,000 | -29.7% | 3,929 | -37.1% | 0.00% | – |
| Q3 2017 | $101,000 | +4950.0% | 6,251 | +3392.2% | 0.00% | – |
| Q2 2017 | $2,000 | -100.0% | 179 | -100.0% | 0.00% | -100.0% |
| Q1 2017 | $5,640,000 | +4.4% | 375,968 | -8.8% | 0.00% | 0.0% |
| Q4 2016 | $5,402,000 | -25.0% | 412,461 | -1.3% | 0.00% | -25.0% |
| Q3 2016 | $7,200,000 | – | 417,900 | +2611775.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 16 | -90.8% | 0.00% | – |
| Q4 2015 | $5,000 | -85.7% | 174 | -87.9% | 0.00% | – |
| Q3 2015 | $35,000 | – | 1,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |